Use of oxytocin and misoprostol for induction or ... - POPPHI

List of Tables
Table 1.1a Published and anecdotal evidence of unsafe use of induction and
augmentation in LRS
Table 2.1a Inclusion and exclusion criteria used in the searches
Table 3.1a Definitions of terms relating to induction and augmentation of labor
Table 3.1b Bishop Score for assessment of cervical readiness for induction
Table 3.3a Examples of high versus low dose regimens for oxytocin induction with
electronic infusion pump (various dose schedules are in use).
Table 3.3b: WHO recommendations for induction by manual rate estimation
Table 3.3c WHO recommendations for induction by manual rate estimation for
primiparous women
Table 3.4a National induction rates in developed countries
Table 3.4b Sub-national rates of elective induction in developed countries
Table 3.4c: The percent distribution (or percentage) of inductions by indication for the
induction; 6 developed countries
Table 3.4d Odds ratios or relative risk and 95% confidence intervals for Cesarean
section following elective induction of labor versus spontaneous onset in
low risk women in developed countries
Table 3.4e Rates, relative risks and odds ratios of neonatal outcomes associated with
elective induction relative to spontaneous labor in 4 developed countries
Table 3.4f Rates and relative risks of neonatal outcomes associated with vaginal
misoprostol relative to dinoprostone
Table 3.5a Percent distribution of public, health-facility based deliveries that were
induced or augmented; 7 developing countries, 2005-2006
Table 3.5b Hospital-specific rates of induction and augmentation in LRS identified in
the literature review
Table 3.5c Rates of augmentation (use of oxytocics during 1 st and 2 nd stages of labor)
cited in developing country studies;
Table 3.5d Hospital-specific rates of elective induction in LRS
Table 3.5e Percent distribution (or percentage) of inductions by indication from
hospital-based studies in LRS
8